Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] — Common Side Effects

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Side Effect Total Reports Drugs Deaths Hosp. Life-Threat.
Bone density decreased 10,727 5 159 660 1
Renal injury 9,371 5 168 526 0
Skeletal injury 8,320 1 172 490 0
Chronic kidney disease 7,417 5 220 918 5
Osteonecrosis 7,293 5 107 470 0
Bone loss 7,052 3 107 382 0
Multiple fractures 6,883 4 110 450 1
Renal failure 6,748 5 347 1,014 21
Osteoporosis 5,746 5 80 581 3
Tooth loss 4,483 1 57 266 0
Drug resistance 3,404 5 119 520 14
Pain 3,284 5 161 561 4
Foetal exposure during pregnancy 3,017 5 388 335 26
Virologic failure 2,858 5 101 147 16
Emotional distress 2,849 2 71 375 0
Pathogen resistance 2,839 5 41 157 6
Anxiety 2,774 5 79 537 2
Viral mutation identified 2,639 5 31 109 0
Anhedonia 2,449 2 57 331 0
Renal impairment 2,329 5 60 431 12
Osteopenia 2,273 3 16 183 0
Drug ineffective 2,101 5 293 297 37
Tooth injury 2,019 3 21 84 0
Blood creatinine increased 1,900 5 39 338 15
Death 1,473 5 1,461 134 38
Acute kidney injury 1,455 4 102 677 51
Treatment failure 1,390 5 120 48 4
Maternal exposure during pregnancy 1,219 4 62 183 14
Exposure during pregnancy 1,213 5 104 150 17
Nephropathy 1,084 4 45 135 0
← Back to Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Compare drugs in this class →